Results 121 to 130 of about 260,092 (192)

Examples of MDR TB care cascades.

, 2019
(A) The care cascade for individuals with MDR TB in India in 2013, modified from [10] based on updated WHO MDR TB incidence estimates [23], and (B) the care cascade for individuals with rifampin-resistant TB in South Africa in 2013 [11].
Vineet K. Chadha (292177), Kenneth H. Mayer (116219), Ramnath Subbaraman (549978), Madhukar Pai (55924), Ruvandhi R. Nathavitharana (3240120), Srinath Satyanarayana (295839), Nimalan Arinaminpathy (88497)   +6 more
core   +1 more source

Treatment outcomes of patients with Multidrug-Resistant Tuberculosis (MDR- TB) compared with Non-MDR-TB infections in peninsular malaysia

, 2016
Background: Treating patients with multidrug-resistant tuberculosis (MDR-TB) strains is more complicated, complex, toxic, expensive, than treating patients with susceptible TB strains.
Azhanie Sardangi
core  

Multidrug resistant tuberculosis (MDR-TB) in Eritrea: a retrospective cohort analysis of mortality and associated factors (2013 - 2023). [PDF]

Front Cell Infect Microbiol
Teumezgi HA, Suud NN, Berhane YM, Said SM, Hailu DT, Habtetsion KK, Weldetnsae TM, Achila OO.   +7 more
europepmc   +1 more source

Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis. [PDF]

Front Cell Infect Microbiol
Kozińska M, Głogowska A, Minias A, Dziadek J, Augustynowicz-Kopeć E.   +4 more
europepmc   +1 more source

XDR TB [PDF]

Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or

core  

Comments on "Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China". [PDF]

J Clin Tuberc Other Mycobact Dis
Katkuri SN, Vadhithala V, Kumar A, Verma S, Dedeepya D.   +4 more
europepmc   +1 more source

Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of <i>Mycobacterium avium Complex</i>-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing. [PDF]

Microorganisms
Rukasha I, Kaapu KG, Nemaguvhuni NF, Wells-Hunter F, Sharma A, Phelan JE, Kolobe MJ, Lekalakala-Mokaba MR, Warren RM, Costa Conceição E.   +9 more
europepmc   +1 more source

Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. [PDF]

New Microbes New Infect
Hongler J, Haller S, Adakun AS, Lutz N, Buzibye A, Kälin M, Castelnuovo B, Sekaggya-Wiltshire C, Abongomera G, Jetter A, Fehr J.   +10 more
europepmc   +1 more source

Multidrug-resistant tuberculosis (MDR-TB): an evolving threat to the Nigerian health system - a review. [PDF]

Ann Med Surg (Lond)
Shehu A, Oduoye MO, Siddiqui AN, Shaikh H, Odhiambo J, Muhsin M, Zubairu AZ, Ezenwoba C, Abdulhadi A, Biamba C, Shakeel L, Alhassan A, Karegeya A, Mugisha MJM, Wei CR, Zihindula F, Ndagano EB, Ntumba TN, Tague C, Akilimali A.   +19 more
europepmc   +1 more source

Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection. [PDF]

J Mass Spectrom
Lokhande RV, Arora PR, Bhagure GR, Joubert A, Udwadia ZF, Rodrigues C, Gupta A, Mave V, Raichur P, Gaikwad S, Khan R, Pradeep A, Wiesner L, Tornheim JA, Horsburgh CR, Ashavaid TF, MDR‐TB MUKT and RePORT India Team, Indo‐South Africa Study Team and PREEMPT Study Teams.   +17 more
europepmc   +1 more source